Skip to main content

Tower Research Capital LLC (TRC)

Position in DXCM — Dexcom Inc

CIK 1533421 NEW YORK, NY

Position in DXCM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,044,516
+$27,599 QoQ
Shares Held
32,556
+7.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Jun 30, 2023
CallValue
$128,510
CallShares
1,000
PutValue
$38,553
PutShares
300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $33,926,514 across 110 Medical Devices names. DXCM ranks #7 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 DXCM
Dexcom Inc
This page
32,556 $2,044,516

All Filings in DXCM

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,044,516 32,556
2025-12-31 $2,016,917 30,389
2025-09-30 $622,163 9,246
2025-06-30 $675,973 7,744
2025-03-31 $572,064 8,377
2024-12-31 $2,803,608 36,050
2024-09-30 $2,440,188 36,399
2024-06-30 $5,826,711 51,391
2024-03-31 $4,441,867 32,025
2023-12-31 $7,780,442 62,700
2023-09-30 $5,359,524 57,444
2023-06-30 $1,078,455 8,392
2023-06-30 $38,553 300
2023-06-30 $128,510 1,000
2023-03-31 $900,627 7,752
2022-12-31 $1,702,449 15,034
2022-09-30 $7,558,517 93,848
2022-06-30 $3,745,728 50,258
2022-03-31 $3,374,385 26,383
2021-12-31 $1,328,145 9,894
2021-09-30 $807,028 5,903
2021-06-30 $354,302 3,319
2021-03-31 $1,133,784 12,619
2020-12-31 $169,609 1,835
2020-09-30 $502,199 4,873
2020-06-30 $202,395 1,997
2020-03-31 $3,567 53